Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : XNCR save search
Xencor Appoints Bart Cornelissen as Chief Financial Officer
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.28%
H: 3.95%
C: 1.32%
financial
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Knight Therapeutics Announces Launch of Minjuvi® in Brazil
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.68%
H: 2.22%
C: -1.92%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -3.07%
minjuvi brazil therapeutics
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.2%
H: 2.52%
C: 1.3%
year financial results
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Published: 2024-02-26 (Crawled : 12:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.29%
H: 7.38%
C: 6.02%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 2.6%
H: 1.87%
C: 0.7%
business year financial results
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-22 (Crawled : 00:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.87%
H: 2.89%
C: 2.14%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -0.69%
H: 2.99%
C: 2.59%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.17%
H: 6.18%
C: 5.4%
year update financial results
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
Published: 2024-02-20 (Crawled : 00:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -1.08%
H: 4.04%
C: -1.63%
year review update financial results
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published: 2024-02-13 (Crawled : 19:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -3.56%
H: 2.91%
C: -3.34%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -0.4%
H: 0.23%
C: -0.46%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: -5.25%
H: 2.94%
C: 2.18%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
financial
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -3.53%
H: 1.53%
C: -0.27%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
year financial results
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)
Published: 2024-02-05 (Crawled : 23:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -1.55%
H: 2.76%
C: 1.84%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.99%
H: 59.84%
C: 54.47%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.6%
H: 0.81%
C: 0.1%
monjuvi global commercialization
MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
Published: 2024-01-30 (Crawled : 09:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: -4.81%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.56%
H: 1.7%
C: -2.77%
sales financial monjuvi
InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Greater Bay Area’s Early Access Program
Published: 2024-01-22 (Crawled : 07:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.56%
H: 1.97%
C: 1.37%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.11%
H: 1.96%
C: -0.27%
first bay program
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 23:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: -2.06%
conference
The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight
Published: 2023-11-22 (Crawled : 22:00) - prnewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
| Email alert
Add to watchlist
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
| Email alert
Add to watchlist
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
| Email alert
Add to watchlist
BPTH | News 0 d | $4.17 -0.71% -0.96% 2.1M
|
Health Technology
| Email alert
Add to watchlist
RVMD S | $34.95 -2.46% -2.52% 1.2M
|
Health Technology
| Email alert
Add to watchlist
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
| Email alert
Add to watchlist
cell market
Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-21 (Crawled : 00:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -1.26%
H: 0.21%
C: -5.8%
conference
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 00:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.38%
H: 4.02%
C: 2.88%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -0.94%
H: 2.53%
C: -6.21%
financial results
Xencor Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.05%
H: 1.41%
C: 0.82%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: -1.47%
H: 11.57%
C: 5.97%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.36%
H: 0.48%
C: -1.09%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.09%
H: 0.35%
C: -0.57%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.05%
H: 0.38%
C: -0.68%
financial results
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
Published: 2023-11-03 (Crawled : 18:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.77%
H: 4.61%
C: 3.65%
xmab research preclinical meeting
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-02 (Crawled : 00:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.32%
H: 0.45%
C: -1.19%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.03%
H: 4.07%
C: 4.07%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 3.4%
H: 0.57%
C: -0.5%
update financial results
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published: 2023-11-02 (Crawled : 18:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.09%
H: 1.03%
C: 0.91%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.32%
H: 0.45%
C: -1.19%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.22%
H: 0.6%
C: -9.4%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.28%
H: 1.0%
C: -0.46%
presentation meeting
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.